MilliporeSigma CEO Eyes New Technologies, Simpler Process for CAR-T Manufacturing – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
MilliporeSigma CEO Eyes New Technologies, Simpler Process for CAR–T Manufacturing
Genetic Engineering & Biotechnology News “The full supply chain is extremely difficult, to say the least. And we have to work together to simplify it,” Dr. Batra told GEN. The supply chain requires coordination between a patient’s primary oncology team and the manufacturing facility where the … |
|
Drugmakers see a pricing blueprint in an $850000 gene therapy
Reuters SAN FRANCISCO (Reuters) – Global drugmakers are looking to a tiny biotech’s $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines. Spark Therapeutics Inc plans to launch its … |
Xconomy |
Bio Roundup: #JPM18, Axovant’s Fall, CRISPR Caveat, Impact M&A & More
Xconomy Have you gotten your flu shot yet this year? This winter’s flu season is shaping up to be a particularly nasty one and the Centers for Disease Control and Prevention this week upped its tally of states reporting widespread flu activity to 46. Flu … |